Audientes AS (XSAT:AUDNTS) Research & Development: kr0.00 Mil (TTM As of Jun. 2025)


What is Audientes AS Research & Development?

Audientes AS XSAT:AUDNTS Research & Development is kr0.00 Mil as of Jun. 2025.

Research & Development is the aggregate amount of research and development expenses during the year. Audientes AS's Research & Development for the three months ended in Jun. 2025 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was kr0.00 Mil.

Audientes AS  (XSAT:AUDNTS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Audientes AS Research & Development Related Terms

Audientes AS Research & Development Historical Data

* Premium members only.

The historical data trend for Audientes AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Audientes AS Research & Development Chart

Audientes AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Audientes AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Audientes AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
Audientes AS (XSAT:AUDNTS) has a Research & Development of kr0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Audientes AS and its competitors.
Is Audientes AS's Research & Development too high?
Audientes AS's current Research & Development is kr0.00 Mil.
How does Audientes AS's Research & Development compare to ISRG and BDX?
Audientes AS's Research & Development of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Audientes AS and its competitors. Audientes AS's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Audientes AS stock overvalued right now?
Audientes AS (XSAT:AUDNTS) has a current Research & Development of kr0.00 Mil. The current Research & Development is kr0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Audientes AS (XSAT:AUDNTS), the current Research & Development is kr0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Audientes AS Business Description

Address Slotsmarken 18, Horsholm, DNK, 2970
Audientes AS is a Danish hearing technology company specializing in smart, self-fitting, and affordable hearing aids. Audientes' hearing aid solutions portfolio comprises Ven, a self-fitting, binaural hearing aid designed for individuals with severe to profound hearing loss in one or both ears, and Companion, a hearable that doubles as a premium Bluetooth headset, designed for individuals seeking enhanced hearing in specific situations. It offers crystal-clear sound, natural speech clarity, and Bluetooth connectivity for calls and media streaming.